Unknown

Dataset Information

0

Identification of binding sites for ivacaftor on the cystic fibrosis transmembrane conductance regulator.


ABSTRACT: Ivacaftor (VX-770) was the first cystic fibrosis transmembrane conductance regulator (CFTR) modulatory drug approved for the treatment of patients with cystic fibrosis. Electron cryomicroscopy (cryo-EM) studies of detergent-solubilized CFTR indicated that VX-770 bound to a site at the interface between solvent and a hinge region in the CFTR protein conferred by transmembrane (tm) helices: tm4, tm5, and tm8. We re-evaluated VX-770 binding to CFTR in biological membranes using photoactivatable VX-770 probes. One such probe covalently labeled CFTR at two sites as determined following trypsin digestion and analysis by tandem-mass spectrometry. One labeled peptide resides in the cytosolic loop 4 of CFTR and the other is located in tm8, proximal to the site identified by cryo-EM. Complementary data from functional and molecular dynamic simulation studies support a model, where VX-770 mediates potentiation via multiple sites in the CFTR protein.

SUBMITTER: Laselva O 

PROVIDER: S-EPMC8184517 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4226057 | biostudies-literature
| S-EPMC7134581 | biostudies-literature
2006-03-24 | GSE4513 | GEO
| S-EPMC3552343 | biostudies-literature
| S-EPMC5036583 | biostudies-literature
| S-EPMC5856801 | biostudies-literature
| S-EPMC9911415 | biostudies-literature
| S-EPMC6822231 | biostudies-literature
| S-EPMC8576290 | biostudies-literature
| S-EPMC1271750 | biostudies-literature